Facetten
Zugriff
Einrichtung
Medientyp
- Text 6
Karte
Erscheinungsjahr
Autor/in
- Lebwohl, M
- Blauvelt, A 3
- Langley, R G 3
- Reich, K 3
- Augustin, M 2
- alle zeigen
Sprache
- Englisch 6
6 Einträge gefunden
-
Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis
2022 - Forschungsinformationssystem des UKE - frei zugänglich -
Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Continued treatment with secukinumab is associated with high retention or regain of response
2020 - Forschungsinformationssystem des UKE -
Use of dose-exposure-response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis
2019 - Forschungsinformationssystem des UKE